Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination to reduce COVID-19-related work absence in healthcare workers
2020-001783-28Phase 3Completed
- Sponsor
- National Koranyi Institute of Pulmonology
- Start
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by National Koranyi Institute of Pulmonology. Primary endpoint: Number of days of unplanned absenteeism because of documented COVID-19 infection. Started Apr 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001783-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001783-28.